Predict your next investment


See what CB Insights has to offer

Founded Year



Acquired | Acquired

About Coripharm

Developer and manufacturer of innovative biomaterials. The company's purpose is to conduct research into the basic scientific and technical principles of new and innovative bone cements and bone substitute materials until they are ready to go into production and to develop innovative production processes and application systems for these products. To be more precise, the company works in the fields of cemented endoprosthetics, biological bone substitutes, and local wound healing. The company's biological preparations have applications in orthopedic surgery and traumatology.

Coripharm Headquarter Location

Lagerstrasse 11-15

Dieburg, 64807,


49 60719290

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.